Segueix
Juan Pablo Horcajada MD, PhD
Juan Pablo Horcajada MD, PhD
Hospital del Mar. Institut Hospital del Mar d'Investigacions Mèdiques (IMIM). Professor of Medicine
Correu electrònic verificat a upf.edu
Títol
Citada per
Citada per
Any
Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections
JP Horcajada, M Montero, A Oliver, L Sorlí, S Luque, S Gómez-Zorrilla, ...
Clinical microbiology reviews 32 (4), 10.1128/cmr. 00031-19, 2019
6952019
Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli
J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ...
Archives of internal medicine 168 (17), 1897-1902, 2008
5692008
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez, JP Horcajada, M Almela, F Marco, A Soriano, MA Marco, ...
Clinical Infectious Diseases 36 (4), 389-395, 2003
5642003
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
Jama 326 (6), 499-518, 2021
4862021
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4742021
Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Peña, ...
Clinical infectious diseases 50 (1), 40-48, 2010
4612010
A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention
J Lora-Tamayo, O Murillo, JA Iribarren, A Soriano, M Sánchez-Somolinos, ...
Clinical infectious diseases 56 (2), 182-194, 2013
4242013
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ...
Clinical Microbiology and Infection 26 (11), 1525-1536, 2020
3632020
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3502021
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
J Rodríguez-Baño, JR Pano-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ...
Enfermedades infecciosas y microbiologia clinica 30 (1), 22. e1-22. e23, 2012
3302012
Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I …
KS Kaye, T Bhowmick, S Metallidis, SC Bleasdale, OS Sagan, V Stus, ...
Jama 319 (8), 788-799, 2018
3122018
Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria
V Cepas, Y López, E Muñoz, D Rolo, C Ardanuy, S Martí, M Xercavins, ...
Microbial Drug Resistance 25 (1), 72-79, 2019
3052019
The early systemic prophylaxis of infection after stroke study: a randomized clinical trial
A Chamorro, JP Horcajada, V Obach, M Vargas, M Revilla, F Torres, ...
Stroke 36 (7), 1495-1500, 2005
2902005
Azithromycin in the treatment of COVID-19: a review
D Echeverría-Esnal, C Martin-Ontiyuelo, ME Navarrete-Rouco, ...
Expert review of anti-infective therapy 19 (2), 147-163, 2021
2862021
Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials?
M Vargas, JP Horcajada, V Obach, M Revilla, A Cervera, F Torres, ...
Stroke 37 (2), 461-465, 2006
2772006
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance
SM Soto, A Smithson, JA Martinez, JP Horcajada, J Mensa, J Vila
The Journal of urology 177 (1), 365-368, 2007
2682007
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
L Sorlí, S Luque, S Grau, N Berenguer, C Segura, MM Montero, ...
BMC infectious diseases 13, 1-9, 2013
2502013
Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
N Benito, M Franco, A Ribera, A Soriano, D Rodriguez-Pardo, L Sorlí, ...
Clinical Microbiology and Infection 22 (8), 732. e1-732. e8, 2016
2402016
Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study
R Terradas, S Grau, J Blanch, M Riu, P Saballs, X Castells, JP Horcajada, ...
Public Library of Science 7 (8), e42860, 2012
2302012
Are Quinolone-Resistant Uropathogenic Escherichia coli Less Virulent?
J Vila, K Simon, J Ruiz, JP Horcajada, M Velasco, M Barranco, A Moreno, ...
The Journal of infectious diseases 186 (7), 1039-1042, 2002
2202002
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20